Speakers 2024

Speakers 2024

Nikolaus S. Trede

Century Therapeutics

Senior Vice President, Head of Clinical Development


MD degree, Freiburg University Supervisor of MD thesis: Radvan Urbanek, magna cum laude DEA immunology, Institut Pasteur, Paris Supervisor: Pierre Andre Cazenave PhD Immunology, Universite Paris VII Supervisor: Raif Geha, summa cum laude Residency in Pediatrics, Children’s Hospital Boston Fellowship in Pediatric Hematology/Oncology, Children’s Hospital and Dana Farber Cancer Institute, Boston Postdoctoral Fellowship in zebrafish immunology in HHMI lab of Leonard Zon, Children’s Hospital Academic Appointments Instructor in Pediatrics, Harvard Medical School Assistant Professor of Pediatrics, University of Utah Medical School and Huntsman Cancer Institute Associate Professor of Pediatrics, University of Utah Medical School and Huntsman Cancer Institute Industry Employment ARIAD Pharmaceuticals, Boston: Medical Director of Clinical Development Acetylon Pharmaceuticals, Boston: Senior Medical Director of Clinical Development Juno Therapeutics/Celgene Corporation/BMS, Seattle: Senior Medical Director of Clinical Development Century Therapeutics, Seattle/Philadelphia: Senior Vice President of Clinical Development Career Statement: Following an academic career with expertise in both Hematology/Oncology as well as immunology with a strong focus on translational research and patient care, I have dedicated myself to bringing new compounds to patients with oncologic and autoimmune diseases in the industry setting. Since 2016 my interest is centered on cell therapy approaches for patients with high unmet need, using both autologous CAR T, as well as iPSC-derived cell product.

Find also